WO2015007922A1 - Pansements et pastilles à l'aloe vera pour blessures et ulcères - Google Patents
Pansements et pastilles à l'aloe vera pour blessures et ulcères Download PDFInfo
- Publication number
- WO2015007922A1 WO2015007922A1 PCT/ES2013/070514 ES2013070514W WO2015007922A1 WO 2015007922 A1 WO2015007922 A1 WO 2015007922A1 ES 2013070514 W ES2013070514 W ES 2013070514W WO 2015007922 A1 WO2015007922 A1 WO 2015007922A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- aloe vera
- sheet
- wounds
- ulcers
- polyurethane
- Prior art date
Links
- 208000027418 Wounds and injury Diseases 0.000 title claims abstract description 32
- 206010052428 Wound Diseases 0.000 title claims abstract description 30
- 235000002961 Aloe barbadensis Nutrition 0.000 title claims abstract description 29
- 235000011399 aloe vera Nutrition 0.000 title claims abstract description 29
- 208000025865 Ulcer Diseases 0.000 title claims abstract description 15
- 231100000397 ulcer Toxicity 0.000 title claims abstract description 13
- 244000186892 Aloe vera Species 0.000 title claims abstract 16
- 229920001296 polysiloxane Polymers 0.000 claims abstract description 22
- 229920002635 polyurethane Polymers 0.000 claims abstract description 20
- 239000004814 polyurethane Substances 0.000 claims abstract description 20
- 238000011282 treatment Methods 0.000 claims abstract description 17
- 230000002265 prevention Effects 0.000 claims abstract description 10
- XQFRJNBWHJMXHO-RRKCRQDMSA-N IDUR Chemical compound C1[C@H](O)[C@@H](CO)O[C@H]1N1C(=O)NC(=O)C(I)=C1 XQFRJNBWHJMXHO-RRKCRQDMSA-N 0.000 claims abstract description 9
- 208000015181 infectious disease Diseases 0.000 claims abstract description 9
- 230000000472 traumatic effect Effects 0.000 claims abstract description 8
- 230000035876 healing Effects 0.000 claims abstract description 7
- 239000000853 adhesive Substances 0.000 claims description 19
- 230000001070 adhesive effect Effects 0.000 claims description 19
- 239000000463 material Substances 0.000 claims description 14
- 230000000774 hypoallergenic effect Effects 0.000 claims description 11
- 230000002745 absorbent Effects 0.000 claims description 7
- 239000002250 absorbent Substances 0.000 claims description 7
- 230000003247 decreasing effect Effects 0.000 claims description 7
- 208000002260 Keloid Diseases 0.000 claims description 6
- 230000001969 hypertrophic effect Effects 0.000 claims description 6
- 210000001117 keloid Anatomy 0.000 claims description 6
- 231100000241 scar Toxicity 0.000 claims description 6
- 230000009467 reduction Effects 0.000 claims description 5
- 230000037390 scarring Effects 0.000 claims description 5
- 208000003251 Pruritus Diseases 0.000 claims description 4
- 239000004744 fabric Substances 0.000 claims description 4
- 230000007803 itching Effects 0.000 claims description 4
- 238000002803 maceration Methods 0.000 claims description 4
- 208000035824 paresthesia Diseases 0.000 claims description 4
- 206010040880 Skin irritation Diseases 0.000 claims description 3
- 208000002847 Surgical Wound Diseases 0.000 claims description 3
- 230000006378 damage Effects 0.000 claims description 3
- 230000006872 improvement Effects 0.000 claims description 3
- 230000036556 skin irritation Effects 0.000 claims description 3
- 231100000475 skin irritation Toxicity 0.000 claims description 3
- 230000002792 vascular Effects 0.000 claims description 3
- 230000000845 anti-microbial effect Effects 0.000 claims description 2
- 239000003795 chemical substances by application Substances 0.000 claims description 2
- 239000003814 drug Substances 0.000 claims description 2
- 208000014674 injury Diseases 0.000 claims description 2
- 230000007794 irritation Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 230000005810 radionecrosis Effects 0.000 claims 2
- 239000003589 local anesthetic agent Substances 0.000 claims 1
- 229940124597 therapeutic agent Drugs 0.000 claims 1
- 230000004071 biological effect Effects 0.000 abstract description 2
- 244000144927 Aloe barbadensis Species 0.000 description 13
- 239000000017 hydrogel Substances 0.000 description 7
- 239000003974 emollient agent Substances 0.000 description 5
- 238000001356 surgical procedure Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 230000029663 wound healing Effects 0.000 description 4
- 230000034994 death Effects 0.000 description 3
- 231100000517 death Toxicity 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- -1 Aloe Vera Substances 0.000 description 2
- 208000032544 Cicatrix Diseases 0.000 description 2
- 208000009889 Herpes Simplex Diseases 0.000 description 2
- 208000031650 Surgical Wound Infection Diseases 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000002350 laparotomy Methods 0.000 description 2
- 230000003902 lesion Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000012188 paraffin wax Substances 0.000 description 2
- 230000037387 scars Effects 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- HBZVNWNSRNTWPS-UHFFFAOYSA-N 6-amino-4-hydroxynaphthalene-2-sulfonic acid Chemical compound C1=C(S(O)(=O)=O)C=C(O)C2=CC(N)=CC=C21 HBZVNWNSRNTWPS-UHFFFAOYSA-N 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 206010011985 Decubitus ulcer Diseases 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000007514 Herpes zoster Diseases 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000019486 Sunflower oil Nutrition 0.000 description 1
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 1
- 208000036142 Viral infection Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010048038 Wound infection Diseases 0.000 description 1
- 229960004150 aciclovir Drugs 0.000 description 1
- MKUXAQIIEYXACX-UHFFFAOYSA-N aciclovir Chemical compound N1C(N)=NC(=O)C2=C1N(COCCO)C=N2 MKUXAQIIEYXACX-UHFFFAOYSA-N 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- 230000000202 analgesic effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000840 anti-viral effect Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000000903 blocking effect Effects 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 210000000038 chest Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 235000012716 cod liver oil Nutrition 0.000 description 1
- 239000003026 cod liver oil Substances 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000010776 emu oil Substances 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- 229940045761 evening primrose extract Drugs 0.000 description 1
- 235000008524 evening primrose extract Nutrition 0.000 description 1
- 229960004396 famciclovir Drugs 0.000 description 1
- GGXKWVWZWMLJEH-UHFFFAOYSA-N famcyclovir Chemical compound N1=C(N)N=C2N(CCC(COC(=O)C)COC(C)=O)C=NC2=C1 GGXKWVWZWMLJEH-UHFFFAOYSA-N 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000036571 hydration Effects 0.000 description 1
- 238000006703 hydration reaction Methods 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 150000002734 metacrylic acid derivatives Chemical class 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 238000011169 microbiological contamination Methods 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 230000004962 physiological condition Effects 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 230000002980 postoperative effect Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 230000001823 pruritic effect Effects 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 238000007634 remodeling Methods 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000018040 scab formation Effects 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000002600 sunflower oil Substances 0.000 description 1
- 239000010677 tea tree oil Substances 0.000 description 1
- 229940111630 tea tree oil Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 230000017423 tissue regeneration Effects 0.000 description 1
- 230000009385 viral infection Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- A61F13/01017—
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/22—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing macromolecular materials
- A61L15/26—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
- A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
- A61L15/40—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons containing ingredients of undetermined constitution or reaction products thereof, e.g. plant or animal extracts
Definitions
- Wounds are physical injuries of the body that are characterized by the alteration of normal tissue continuity, can cause damage to superficial skin structures and structures underlying the skin. Of different etiologies, surgical, traumatic, by burn, ulcers, infection, etc., may take weeks to heal or even Get infected with important consequences. The wound healing process goes through several complex and distinct phases while overlapping in order to ensure tissue repair. Sometimes problems arise of repair in the form of hypertrophic scars and keloids that cause patient problems
- Surgical wound infections occur in approximately 1-5% of cases of clean surgery, 5-15% of surgery clean-contaminated, 15-30% of contaminated surgery and up to 30-40% in cases of dirty surgeries, despite a correct antibiotic prophylaxis.
- a wound surgery that requires healing by second intention because it has infected means a daily commitment from the patient and the media sanitary that can last several weeks or months until the healing is has completed, which implies a high health cost, not well quantified.
- 75% of all surgical infections Postoperative are due to superficial infections of the surgical site.
- surgical site infections increase the risk of death about 2-11 times, with 77% of these deaths attributed directly to the infection.
- new agents are needed to help to reduce wound infections in their different forms, to reduce healing time and complications thereof, since they can cause a deterioration of the patient's quality of life by requiring a additional treatment in the healing of complicated wounds, for prolonging the hospital stay, delay the application of other treatments or even cause his death.
- Aloe vera is commonly used by topical route in wound healing and dermatology.
- numerous studies suggest that Aloe vera, in one or more of its constituents, promote wound healing due to its antioxidant activity and anti-inflammatory and for its analgesic and antimicrobial effect on wounds acute or chronic Herpes is a common viral infection that occurs in Herpes simplex or Zoster form. It produces pruritic vesicular lesions and Highly contagious and recurrent painful that break leading to scab formation ulcerations becoming sometimes disabling.
- Acyclovir or famciclovir-based treatments are used indiscriminately in the treatment of common herpes simplex when it should be reserved to treat the possible complications of herpes such as encephalitis and thus avoid Resistance of the virus to these drugs due to its misuse.
- the properties Aloe vera described and its proven antiviral effect make it ideal for Topical treatment of this problem.
- the objective of the present invention is to provide dressings and patches with Aloe vera for the treatment of a wide variety of wounds
- Document GB 0128152 describes a multilayer dressing for wounds comprising: a liquid permeable topsheet that has a surface that rests on the wound and a posterior surface, said sheet upper adapts to block or restrict the passage of liquid from the posterior surface towards the surface that rests on the wound; and a layer of hydrogel coated or bonded to the back surface of the topsheet.
- the dressing also contains an absorbent layer separated from the hydrogel layer, located on the opposite side of the hydrogel layer from the top sheet.
- Suitable polymers to form the backing sheet include polyurethanes and polyalkoxyalkylacrylates and methacrylates such as which are described in GB-A-1280631.
- the term 'hydrogel' refers to generally to materials that interact with the low wound fluid physiological conditions to maintain a high humidity level in the wound surface.
- the hydrogel layer may contain one or more emollients, alternatively or additionally to the macromolecules forming gel.
- Emollients are used to soften the surface of the skin and to Increase the degree of hydration. Emollients act either by blocking the loss of water from the outer layer of the skin, or improving water binding To the skin.
- Preferred emollients include Soft White Paraffin, Paraffin Soft Yellow, liquid paraffin, Urea Creams, Lanolin, Sodium Pyrrolidoncarboxylate (PCA Na), evening primrose extract (gamma acid linolenic), Soybean Oil, Tea Tree Oil, coconut Oil, Oil Almond, Chamomile Extract, Cod Liver Oil, Peanut Oil, Emu Oil, Aloe Vera, Sunflower Oil, avocado Oil, Oil Jojoba, Cocoamida, and mixtures thereof.
- PCA Na Sodium Pyrrolidoncarboxylate
- Soybean Oil Tea Tree Oil, coconut Oil, Oil Almond, Chamomile Extract, Cod Liver Oil, Peanut Oil, Emu Oil, Aloe Vera, Sunflower Oil, avocado Oil, Oil Jojoba, Cocoamida, and mixtures thereof.
- the present invention of dressings with Aloe Vera differs from the multilayer dressing mentioned in GB 0128152 in that it is a dressing (Figure 1) that has no hydrogel, is sterile and is consisting of one or two sheets, preferably a top sheet of polyurethane or other liquid impervious or semipermeable materials such as those described in GB-A-1280631, and a lower sheet of silicone or polyurethane, multi-perforated, adhesive and hypoallergenic in Skin contact. Said bottom sheet contains an adhesive except in the area of the same that is in direct contact with the wound. In the central zone of the dressing, between the two sheets a fabric gauze, polyurethane or Other absorbent material.
- Said space between both sheets contains Aloe Vera over the entire length of the dressing, the Aloe vera concentration being higher in the central area where it spreads directly to the wound and to the areas perilesional through the perforations of the adhesive sheet with two intentions, the first exercise its beneficial biological properties on the wound mentioned above and the second decrease lesions by healthy perilesional skin irritation such as erythema, vesicles and so common ulceration observed in clinical practice due to the effect of dressings.
- the dressing consists of a silicone sheet, polyurethane or other waterproof, hypoallergenic material, containing adhesive on the surface of it in contact with the skin, so that Aloe vera It is included in the entire length of the sheet, which presents in the area central a fabric gauze, polyurethane or other absorbent material impregnated in Aloe Vera.
- the sheet is adhesive except in the area of it that is in direct contact with the wound.
- Aloe vera therefore, is spread all over the dressing and not only in the hydrogel described in GB 0128152, and its function is not only to block the loss of water from the outer layer of the skin to maintain a relative degree of humidity, or improve the binding of water to the skin as described in the use of emollients of GB-A-1280631, but preferably, prevention and treatment of infections, decreased pain and improvement of wound healing, as well as reduction of maceration, itching and irritations of the perilesional skin that can produce dressings in the treatment of surgical, traumatic wounds, by Burn or herpes
- the sections of the two-sheet dressing where the top sheet is observed Waterproof (LS) and silicone bottom sheet (LI), adhesive and multi-perforated, in the species between both Aloe Vera (AV) is located in all its extension and in the central area of the gauze or other absorbent material (MA).
- Figure 2 by way of example, they are shown sterile rectangular dressings of different sizes in length and width composed of a polyurethane top sheet and a bottom sheet of 0.5 to 1 mm thick silicone, transparent, adhesive (on the margin indicated around the gauze), multi-perforated and hypoallergenic containing between both Aloe vera in all its extension with a central zone composed by a sterile absorbent gauze of 2mm thickness of different sizes in length and width.
- the dressing form in crescent, 5cm wide and 12cm long, of the same characteristics that the dressing of figure 2, with a gauze of 2cm wide and 9 cm long with an adhesive margin of 1.5cm, indicated in surgical wounds cervical or transverse laparotomy.
- silicone and polyurethane in their different forms of presentation has proven mechanical effects of grip on wounds that confer the property of reducing hypertrophic scars and keloids that have an important impact aesthetics about the people who suffer them depending on the affected areas. Both are considered complications of wound remodeling and when are important can cause problems of lack of elasticity in limbs lower or thorax with limitations of movement and decreased vital respiratory capacity.
- the present invention also provides patches. constituted by sterile sheets of silicone or polyurethane with Aloe vera, of preferably, composed of a silicone or polyurethane top sheet or other waterproof materials, transparent or not, and other bottom sheet of silicone or polyurethane, transparent, multi-perforated and hypoallergenic that Contains adhesive throughout its length, so that Aloe Vera is distributed homogeneously between the two sheets. Or patches consisting of a Only waterproof, transparent, multi-perforated silicone sheet hypoallergenic that contains adhesive throughout its length and is impregnated Aloe vera throughout its surface.
- the main functions of these sheets are the prevention and treatment of complications arising from the scarring (hypertrophic scar and keloids) and decreased Dysesthesias in the treatment of surgical, traumatic wounds, for burn or herpes, as well as reducing maceration, itching and skin irritations that produce patches in general and that require usually the temporary suspension of the patch.
- a section of sterile silicone patches composed of two sheets where the waterproof top sheet (LS) and the bottom sheet of silicone, adhesive and multi-perforated (LI), the space between the two is located Aloe Vera (AV).
- patches are shown in Figure 5 Sterile rectangular silicone of different sizes in length and width consisting of a waterproof 0-5-1mm silicone top sheet and a 0.5-1 mm thick silicone bottom sheet, transparent, adhesive, multi-perforated and hypoallergenic that contain both Aloe vera in all its extension.
- figure 6 by way of example, the form is shown of the sterile silicone crescent patch, 1.5cm wide and 10cm long, of the same characteristics as the sheet of figure 5, indicated by preference in cervical surgical wounds or transverse laparotomy.
- dressings and sheets are covered on its adhesive face by a sheet of protective paper that is removed at the time of placement, protecting the sheet that contacts the skin of contamination and are deposited in a container that prevents microbiological contamination
Abstract
La présente invention concerne la conception de pansements et de pastilles à teneur élevée en aloe vera qui combinent l'efficacité des propriétés mécaniques de la silicone ou du polyuréthane aux propriétés biologiques de l'aloe vera pour traiter et prévenir les infections, diminuer la douleur et les complications engendrées par la cicatrisation des plaies chirurgicales, traumatiques, causées par une brûlure, par l'herpès et la cicatrisation des ulcères.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2013/070514 WO2015007922A1 (fr) | 2013-07-16 | 2013-07-16 | Pansements et pastilles à l'aloe vera pour blessures et ulcères |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/ES2013/070514 WO2015007922A1 (fr) | 2013-07-16 | 2013-07-16 | Pansements et pastilles à l'aloe vera pour blessures et ulcères |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2015007922A1 true WO2015007922A1 (fr) | 2015-01-22 |
Family
ID=52345768
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/ES2013/070514 WO2015007922A1 (fr) | 2013-07-16 | 2013-07-16 | Pansements et pastilles à l'aloe vera pour blessures et ulcères |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2015007922A1 (fr) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107890582A (zh) * | 2017-11-27 | 2018-04-10 | 刘名倬 | 一种硅凝胶联合中药组方治瘢痕敷料的制备方法 |
CN110393634A (zh) * | 2019-06-28 | 2019-11-01 | 孙秀梅 | 一种用于治疗动静脉穿刺术后皮下损伤的治疗膜 |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060359A1 (fr) * | 2002-12-31 | 2004-07-22 | Ossur Hf | Pansement pour blessure |
WO2007096924A2 (fr) * | 2006-02-20 | 2007-08-30 | Maiello, Adolfo | Extraction, préparation et utilisation de principes actifs de l'aloès pour la réalisation de dispositifs d'automédication tels que des gazes, des pansements, des bas, des bandes élastiques et des semelles orthopédiques à libération contrôlée d'aloès |
GB2462678A (en) * | 2008-08-21 | 2010-02-24 | Univ Bolton | Wound treatment |
CN103055107A (zh) * | 2013-02-06 | 2013-04-24 | 贺军 | 一种芦荟伤口贴及其制备方法 |
-
2013
- 2013-07-16 WO PCT/ES2013/070514 patent/WO2015007922A1/fr active Application Filing
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2004060359A1 (fr) * | 2002-12-31 | 2004-07-22 | Ossur Hf | Pansement pour blessure |
WO2007096924A2 (fr) * | 2006-02-20 | 2007-08-30 | Maiello, Adolfo | Extraction, préparation et utilisation de principes actifs de l'aloès pour la réalisation de dispositifs d'automédication tels que des gazes, des pansements, des bas, des bandes élastiques et des semelles orthopédiques à libération contrôlée d'aloès |
GB2462678A (en) * | 2008-08-21 | 2010-02-24 | Univ Bolton | Wound treatment |
CN103055107A (zh) * | 2013-02-06 | 2013-04-24 | 贺军 | 一种芦荟伤口贴及其制备方法 |
Non-Patent Citations (1)
Title |
---|
DATABASE WPI Derwent World Patents Index; AN 2013-P86062 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107890582A (zh) * | 2017-11-27 | 2018-04-10 | 刘名倬 | 一种硅凝胶联合中药组方治瘢痕敷料的制备方法 |
CN110393634A (zh) * | 2019-06-28 | 2019-11-01 | 孙秀梅 | 一种用于治疗动静脉穿刺术后皮下损伤的治疗膜 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2441375T3 (es) | Parche para el tratamiento del herpes labial | |
ES2387804T3 (es) | Métodos de administración un agente dermatológico a un sujeto | |
ES2333490T3 (es) | Aposito mejorado para heridas. | |
ES2258669T3 (es) | Un aposito para heridas. | |
ES2236306T3 (es) | Apositos adaptables. | |
ES2820862T3 (es) | Un apósito médico | |
BR102018007306A2 (pt) | processo para fabricação de fita /placa/ curativo cicatrizante de silicone aderente com formatos específicos | |
US5609569A (en) | Dressing for axilla and upper torso | |
Vuolo | Hypergranulation: exploring possible management options | |
US20130158635A1 (en) | Pain management system | |
ES2929890T3 (es) | Apósito para heridas | |
BR112015013374B1 (pt) | luva hemostática adaptada para ser usada por um usuário e kit | |
US10874555B2 (en) | Wound dressing | |
WO2015007922A1 (fr) | Pansements et pastilles à l'aloe vera pour blessures et ulcères | |
Robb et al. | Phenol cauterisation in the management of ingrowing toenails | |
US20130138055A1 (en) | Specially-shaped bandages for treating warts on human digits | |
CN204016935U (zh) | 一种医用生物磁性敷料贴 | |
KR102026319B1 (ko) | 개량형 상처치료용 부재 | |
Fowler et al. | Split-thickness skin graft donor sites | |
ES2261194T3 (es) | Dispositivo ceramico para tratamiento de heridas. | |
Telfer et al. | Wound care after office procedures | |
CN201389127Y (zh) | 碳纤维敷贴 | |
WO2010037882A1 (fr) | Composition cosmétique pour peaux sensibles | |
ES2842961T3 (es) | Apósito para heridas | |
CN220360497U (zh) | 一种具有局麻止痛功能的创可贴 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 13889478 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 13889478 Country of ref document: EP Kind code of ref document: A1 |